Clinical trial

Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer Patients

NCT00327288

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-10-01

PhasePHASE1

Study timeline

Study start (unknown)2005-10-01Date precision: month

Registry last updated2015-06-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non-small Cell Lung Cancerunresolved

Breast Cancerunresolved

Prostate Cancerunresolved

Interventions

imexonDRUG

docetaxelDRUG · verified · RxNorm: docetaxel

Sponsors & collaborators

AmpliMed Corporationlead sponsor

Mapped research locations

HoustonTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00327288 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.